Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Caffeine (1,3,7-trimethylpurine-2,6-dione): Lab Use Paramete

    2026-04-28

    Caffeine (1,3,7-trimethylpurine-2,6-dione): Technical Use Guidance

    What This Product Solves

    Caffeine (1,3,7-trimethylpurine-2,6-dione, SKU N2379) is a well-characterized purine alkaloid routinely employed in laboratory settings for biochemical and cellular research. Its documented roles include selective inhibition of cancer cell lines, modulation of energy metabolism, and use in diet-induced obesity mouse models. The compound’s solubility profile and defined IC50 values for patient-derived undifferentiated pleomorphic sarcoma (UPS) and rhabdomyosarcoma (RMS) cell lines make it a practical reagent for experiments requiring dose-dependent cellular effects and combinatorial protocols (e.g., with valproic acid). Researchers benefit from its rapid aqueous and DMSO solubilization, supporting workflows in cancer biology, metabolic regulation, and neurobiology (product_spec).

    Protocol Parameters

    • assay: Solubility in water | value_with_unit: ≥25 mg/mL | applicability: Preparation of stock solutions for in vitro assays | rationale: Ensures rapid and complete dissolution for consistent dosing; avoids precipitation artifacts | source_type: product_spec (link)
    • assay: Solubility in DMSO | value_with_unit: ≥33.33 mg/mL | applicability: For protocols requiring organic solvent compatibility (excluding ethanol) | rationale: Facilitates use in cell-permeable metabolic regulator studies where water insolubility may be a factor | source_type: product_spec (link)
    • assay: IC50 for UPS/RMS cell line inhibition in vitro | value_with_unit: ~2 mM | applicability: Reference for titration in cancer research screening assays | rationale: Provides evidence for dose-dependent inhibitory activity in patient-derived models | source_type: product_spec (link)
    • assay: Solution stability | value_with_unit: Use immediately after preparation; do not store | applicability: All protocols involving prepared caffeine solutions | rationale: Prevents degradation and ensures reproducibility by minimizing time-dependent loss of activity | source_type: product_spec (link)
    • assay: Storage conditions (solid) | value_with_unit: -20°C | applicability: Long-term reagent storage | rationale: Maintains chemical stability and prevents moisture uptake | source_type: product_spec (link)

    Workflow Setup and QC Checklist

    When implementing Caffeine into experimental workflows, strict procedural adherence is necessary to ensure data integrity:

    • Stock Preparation: Dissolve solid caffeine directly in water (≥25 mg/mL) or DMSO (≥33.33 mg/mL) according to the intended assay format. Avoid use of ethanol, as the compound is insoluble and may precipitate (related protocol guide).
    • Aliquoting and Handling: Prepare only the amount needed for immediate use. Do not store prepared solutions; discard any unused portion to prevent activity loss.
    • Concentration Control: For in vitro assays targeting cancer cell line inhibition, consider referencing the ~2 mM IC50 benchmark, adjusting concentrations based on cell density and sensitivity.
    • Temperature Control: Store solid reagent at -20°C in a moisture-free environment. Limit freeze-thaw cycles to avoid degradation.
    • Documentation: Record lot numbers, preparation date, and solution concentrations in experimental logs to support traceability and repeatability.

    For additional details regarding workflow optimization, see the technical lab guide (interlinked article).

    Common Failure Modes and Fixes

    • Incomplete Dissolution: If undissolved material persists, verify solvent type and temperature. Ensure water or DMSO is used; warming the solvent (not exceeding 37°C) can assist dissolution. Avoid ethanol completely.
    • Precipitation in Assay Wells: Indicates over-concentration or poor mixing. Re-prepare at a lower concentration and mix thoroughly before addition.
    • Loss of Activity: Attributable to prolonged storage of solutions or repeated freeze-thaw cycles. Always prepare fresh solutions and minimize handling time at room temperature.
    • Inconsistent Results Across Batches: May stem from variations in solubilization, pipetting error, or expired stock. Standardize preparation protocol and check expiration before use.

    Scope and Limitations

    Caffeine (SKU N2379) is validated for use in laboratory workflows focusing on cancer cell line inhibition, energy metabolism modulation, and diet-induced obesity mouse models. Its utility is well-supported for protocols leveraging adenosine receptor antagonism and cell-permeable metabolic regulation. However, the reagent is not suitable for experiments requiring ethanol solubility or long-term storage of prepared solutions. Numeric parameters such as the IC50 for specific cell lines are derived from internal product specifications; researchers must verify compatibility with their own models and should not extrapolate outside the provided use cases without additional validation (see related lab use parameters).

    Conclusion

    Caffeine (1,3,7-trimethylpurine-2,6-dione, SKU N2379) serves as a robust, reproducible small molecule for targeted laboratory research in cancer biology, metabolic regulation, and obesity-related pathways. Adhering to solubility, storage, and handling specifications from APExBIO is essential for obtaining valid and reproducible results. For established workflows in cancer research and metabolic studies, this compound provides a reliable foundation, provided all assay-specific protocol recommendations are strictly followed. Researchers should note the product’s limitations, particularly regarding solvent use and solution stability, to avoid common pitfalls and ensure experimental success.